$MIBE
Miami Breeze Car Care Inc

2024 Q2 Form 10-Q Financial Statement

#000152013824000200 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $2.249K $1.703K
YoY Change -47.86% -70.29%
Cost Of Revenue $951.00 $959.00
YoY Change -48.12% -63.95%
Gross Profit $1.298K $744.00
YoY Change -47.66% -75.79%
Gross Profit Margin 57.71% 43.69%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $97.77K $127.5K
YoY Change -45.27% -64.63%
Operating Profit -$96.47K -$126.7K
YoY Change -45.24% -64.53%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$30.00 -$668.00
YoY Change -96.95% -230.72%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$96.50K -$127.4K
YoY Change -45.53% -64.29%
Net Earnings / Revenue -4290.75% -7481.91%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 33.61M shares 33.53M shares
Diluted Shares Outstanding 33.61M shares 33.53M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $28.08K $58.92K $74.89K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $105.0K $103.8K $103.9K
Prepaid Expenses $2.080K $20.83K $21.03K
Receivables
Other Receivables
Total Short-Term Assets $135.1K $183.5K $199.8K
YoY Change -80.88%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $10.00K $10.00K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $135.1K $183.5K $199.8K
Total Long-Term Assets $10.00K $10.00K $0.00
Total Assets $145.1K $193.5K $199.8K
YoY Change -80.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $77.03K $28.91K $23.81K
YoY Change 30.32%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $77.03K $28.91K $23.81K
Total Long-Term Liabilities
Total Liabilities $77.03K $28.91K $23.81K
YoY Change 30.32%
SHAREHOLDERS EQUITY
Retained Earnings -$3.655M -$3.559M -$3.431M
YoY Change 32.98%
Common Stock $3.361K $3.361K $3.347K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $68.12K $164.6K $176.0K
YoY Change
Total Liabilities & Shareholders Equity $145.1K $193.5K $199.8K
YoY Change -80.88%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$96.50K -$127.4K
YoY Change -45.53% -64.29%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$81.97K
YoY Change -9.2%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $66.00K
YoY Change
NET CHANGE
Cash From Operating Activities -$81.97K
Cash From Investing Activities
Cash From Financing Activities $66.00K
Net Change In Cash -$15.97K
YoY Change -82.31%
FREE CASH FLOW
Cash From Operating Activities -$81.97K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
CY2023Q1 CIK0001872066 Increase Decrease In Prepaid Expenses Related Party
IncreaseDecreaseInPrepaidExpensesRelatedParty
usd
CY2023Q1 us-gaap Payments For Delayed Tax Exempt Exchange
PaymentsForDelayedTaxExemptExchange
usd
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33606966 shares
CY2024Q1 us-gaap Cash
Cash
58920 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
103776 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2964 usd
CY2024Q1 CIK0001872066 Prepaid Expenses Related Party
PrepaidExpensesRelatedParty
17870 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
183530 usd
CY2024Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
10000 usd
CY2024Q1 us-gaap Assets
Assets
193530 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
28909 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
28909 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23809 usd
CY2024Q1 us-gaap Liabilities
Liabilities
28909 usd
CY2023Q4 us-gaap Liabilities
Liabilities
23809 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q1 CIK0001872066 Preferred Stock Shares Designated
PreferredStockSharesDesignated
1000000 shares
CY2023Q4 CIK0001872066 Preferred Stock Shares Designated
PreferredStockSharesDesignated
1000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33606966 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33606966 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
3361 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3347 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3719662 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3603676 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3558502 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3431085 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
164621 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
176038 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
193530 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
199847 usd
CY2024Q1 us-gaap Revenues
Revenues
1703 usd
CY2023Q1 us-gaap Revenues
Revenues
5733 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
959 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
2660 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
744 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
3073 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
18468 usd
CY2024Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
2313 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
8192 usd
CY2024Q1 CIK0001872066 Stockbased Professional Fees
StockbasedProfessionalFees
40000 usd
CY2023Q1 CIK0001872066 Stockbased Professional Fees
StockbasedProfessionalFees
266667 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
55625 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
277717 usd
CY2024Q1 CIK0001872066 Professional Fees Related Party
ProfessionalFeesRelatedParty
62000 usd
CY2023Q1 CIK0001872066 Professional Fees Related Party
ProfessionalFeesRelatedParty
43500 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7555 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12537 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
127493 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
360414 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-126749 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-357341 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-668 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
511 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-668 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
511 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-127417 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-356830 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33527955 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33527955 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33471966 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33471966 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
176038 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
40000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
76000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-127417 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
164621 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1026950 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-356830 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-127417 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-356830 usd
CY2024Q1 CIK0001872066 Stockbased Professional Fees
StockbasedProfessionalFees
40000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-157 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-664 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2809 usd
CY2024Q1 CIK0001872066 Increase Decrease In Prepaid Expenses Related Party
IncreaseDecreaseInPrepaidExpensesRelatedParty
-3000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5100 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-774 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-81969 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90273 usd
CY2024Q1 us-gaap Payments For Delayed Tax Exempt Exchange
PaymentsForDelayedTaxExemptExchange
10000 usd
CY2024Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
76000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
66000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-15969 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-90273 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74889 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
462729 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58920 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-127417 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-356830 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3558502 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3431085 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-81969 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90273 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zRKjRPnHhr15" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zTUAzpz5ZBlh">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates during the three months ended March 31, 2024 and 2023 include estimates for obsolete or slow-moving inventory and the fair value of non-cash equity transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
103776 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
103933 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20834 usd
CY2024Q1 CIK0001872066 Prepaid Expenses Related Party
PrepaidExpensesRelatedParty
17870 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21025 usd
CY2023Q4 CIK0001872066 Prepaid Expenses Related Party
PrepaidExpensesRelatedParty
20870 usd
CY2024Q1 us-gaap Advertising Expense
AdvertisingExpense
2313 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
8192 usd
CY2024Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2024Q1 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 CIK0001872066 Preferred Stock Shares Designated
PreferredStockSharesDesignated
1000000 shares
CY2023Q4 CIK0001872066 Preferred Stock Shares Designated
PreferredStockSharesDesignated
1000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2024Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
95000 shares
CY2024Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
76000 usd
CY2024Q1 us-gaap Share Price
SharePrice
0.80
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd

Files In Submission

Name View Source Status
0001520138-24-000200-index-headers.html Edgar Link pending
0001520138-24-000200-index.html Edgar Link pending
0001520138-24-000200.txt Edgar Link pending
0001520138-24-000200-xbrl.zip Edgar Link pending
cik0001872066-20240331.xsd Edgar Link pending
cik0001872066-20240331_cal.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
miami-20240331_10q.htm Edgar Link pending
miami-20240331_10qex31z1.htm Edgar Link pending
miami-20240331_10qex31z2.htm Edgar Link pending
miami-20240331_10qex32z2.htm Edgar Link pending
R1.htm Edgar Link pending
cik0001872066-20240331_def.xml Edgar Link unprocessable
cik0001872066-20240331_lab.xml Edgar Link unprocessable
cik0001872066-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
miami-20240331_10q_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending